Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001592342-18-000002
Filing Date
2018-01-05
Accepted
2018-01-05 12:11:10
Documents
1
Effectiveness Date
2018-01-05
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9444
  Complete submission text file 0001592342-18-000002.txt   10621
Mailing Address 670 NORTH COLLEGE STREET SUITE B AUBURN AL 36830
Business Address 670 NORTH COLLEGE STREET SUITE B AUBURN AL 36830 334-329-5601
Vitruvias Therapeutics, Inc. (Filer) CIK: 0001592342 (see all company filings)

EIN.: 463308985 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-301275 | Film No.: 18512675